The cytotoxic T lymphocyte antigen 4 (CTLA4) acts as a potent negative regulator of T-cell response, and has been suggested as a pivotal candidate gene for autoimmune disorders such as Graves' disease, type 1 diabetes and autoimmune hypothyroidism, among others. Several single-nucleotide polymorphisms (SNPs) have been proposed as the susceptibility variants, or to be in strong linkage disequilibrium (LD) with the variant. Nevertheless, contradictory results have been found, which may be due to lack of knowledge of the genetic structure of CTLA4 and its geographic variation. We have typed 17 SNPs throughout the CTLA4 gene region in order to analyze the haplotype diversity and LD structure in a worldwide population set (1262 individuals from 44 populations) to understand the variation pattern of the region. Allele and haplotype frequency differentiation between populations is consistent with genomewide averages and points to a lack of strong population-specific selection pressures. LD is high and its pattern is not significantly different within or between continents. However, haplotype composition is significantly different between geographical groups. A continent-specific set of haplotype tagging SNPs has been designed to be used for future association studies. These are portable among populations, although their efficiency might vary depending on the population haplotype spectrum.
Introduction
CTLA4 (cytotoxic T lymphocyte antigen 4) is a member of the immunoglobulin supergene family that functions as a potent negative regulator of T-cell response, 1,2 its lack causing massive lymphoproliferative disorders, fatal multiorgan destruction and early death in knockout and CTLA4-deficient mice.
3 CTLA4 gene is located at position 2q33 in a region also containing the ICOS and CD28 genes, and shares with the latter a high nucleotide identity strongly suggesting that they are the result of a gene duplication. 4 CTLA4 is composed of four exons encoding different functional domains: a leader sequence, and extracellular, transmembrane and cytoplasmic domains. Two amino-acid replacement SNPs have been described for this gene: 49 A/G (T17A) in exon 1 and 2814 G/A in exon 2 (M90I), the latter described in African Americans. 5 Several other single-nucleotide polymorphisms (SNPs) have also been described in the promoter region and at the 3 0 -end of the gene, 6, 7 as well as an (AT)n in the 3 0 -unstranslated region. Owing to its crucial role in T-cell regulation, CTLA4 has been shown to act as a primary determinant of susceptibility to autoimmune disorders; actually, CTLA4 has been shown to be robustly associated with Graves' disease, 8 while some of the SNPs mentioned above have been proposed as the susceptibility variant of disease or to be in strong linkage disequilibrium (LD) with it in different human populations. þ 49 G has been related to multiple diseases, including type 1 diabetes (T1D), 9 rheumatoid arthritis, 10 multiple sclerosis, 11 Graves' disease, 12 asthma, 13 or systemic sclerosis. 14 SNP À1722 has been related to lupus erythematosus in two contradictory studies, 15, 16 while the À1661 G variant has been suggested to be associated with T1D. 17 Also, SNPs 6230 G, 10 717 G, 10 242 G and 12 310 T have been related to GD, autoimmune hypothyroidism and T1D. 7 Nonetheless, the associations have not been always replicated in different populations.
Haplotype and LD analyses have revealed themselves as being a powerful tool to map disease genes 18 as well as to disclose the history of human populations (Betranpetit et al 19 and references therein). In that sense, studies in different loci have shown higher haplotype diversity and lower LD values in African populations than in non-African ones (Tishkoff et al 20 and Sawyer et al 21 and references therein), which is explained by the 'out-of-Africa' hypothesis of human dispersal, the subsequent founder effect in non-African populations and the larger effective population size of African populations. However, LD patterns are more complex than this simple difference between Africans and nonAfricans. 21, 22 With the availability of large SNP data sets, a structure of haplotype blocks with a very low recombination rate separated by hot-spots of recombination has been suggested, 23, 24 the genome being organized in blocks shorter in Africans than in Europeans or Asians. 25 The presence of these high LD regions allows definition of haplotype tagging SNPs (tag-SNPs), that is, the minimum set of SNPs that would capture most of the haplotype diversity within a block. 6 CTLA4 is one of the nine genes where the term tag-SNP was first defined. However, both the presence of blocks and the use of tagSNPs as markers for disease genes are controversial. 26, 27 Moreover, tag-SNPs identified in one population may not be applicable to other populations 28 even if they seem to be quite general for Europeans. 29 Furthermore, Crawford et al, 30 after analyzing the sequence diversity in 100 human genes, concluded that the amount of LD and the haplotype structure should be empirically analyzed in order to assess which and how many SNPs must be typed in a specific gene to detect an association with a disease-causing SNP in a case-control study.
The aim of the present study is to analyze the haplotype diversity within the CTLA4 gene region in a worldwide population set in order to establish its structure, define LD patterns and haplotypes, provide a standard set of markers with known variation for further studies in populations of different ethnic or geographic origin and shed light on the discrepancies found in association studies. Figure 1a shows, for the 17 SNPs analyzed, their position, the allelic variants and the ancestral states deduced from the primate samples. All SNPs and populations were in Hardy-Weinberg equilibrium after Bonferroni correction for multiple testing. Table 1 summarizes several parameters for each population and geographical region, including the number of fixed (monomorphic) alleles. As shown in Figure 2 , all the SNPs analyzed are highly polymorphic worldwide except for SNP -658, which shows little polymorphism in Europeans, North Africans and Middle Easterners, and reaches fixation in most other populations; and SNP -319, which is also fixed in a large number of samples.
Results

Polymorphism and haplotype description
Ancestral alleles (Table 2) were generally more frequent than the derived alleles, which argues against a recent selective sweep at CTLA4 in the human lineage. Divergence between the human and the chimpanzee CTLA4 sequences is 1.085%, close to the average humanchimpanzee divergence 31 and consistent with a lack of accelerated nucleotide divergence for this gene.
In order to test for SNP frequency differences, both between SNPs and between populations, F ST values were calculated by SNP and by geographic regions ( Table 2 ). The average F ST for all 44 populations is B0.10, in agreement with previous studies of neutral markers. [32] [33] [34] When instead of 44 independent populations the eight continental groups are considered, there is only a slight decrease in the F ST values. As expected, the highest continental F ST value is found in sub-Saharan Africa, with very low values and extreme homogeneity within Europe, North-Africa and Central/South Asia. For these continents, AMOVA (analysis of molecular variance) shows no statistical significance, in contrast to the highly significant values for sub-Saharan Africa, Middle East and East Asia. When a two-tier AMOVA (continental groups and populations) is applied, most differences are within populations (89.2%), a high proportion among regional groups (8.5%) and a mere 2.3% among populations within regional groups.
When comparing F ST among SNPs, a maximum differentiation is found for SNP 6230 (0.137 between continental groups), which has been associated to disease. 7 However, F ST values are not significantly different between disease-related and nondisease-related Table 2 ) fall close to the mean for 369 markers. 36 This suggests that the geographic stratification shown by CTLA4 is well below a genomewide average and points to the absence of strong geographically specific selective pressures.
A total of 181 haplotypes were estimated, of which 68 account for 95% of the global variation. The cumulative frequency of the nine most frequent haplotypes is 79%, the 10th adding only 1.27%. As shown in Figure 3 , which represents haplotype composition for world regions all over the world, neither the number of haplotypes nor their distribution are homogeneous even for the most frequent ones. Out of the 180 haplotypes, 72 (40%) were found in more than one population and 63 (35%) were found in more than one continental region. The ancestral haplotype estimated from primate data is not present in our sample; the haplotypes most similar to the ancestral are h152 and h165, with only one change each. Both haplotypes are rare (maximum two chromosomes), h152 being present in two chromosomes from two different African populations and a single h165 chromosome being private to Bantus. Table 1 shows haplotype descriptive parameters for each population and averaged by geographical groups. Haplotype diversity (Dh, that is, expected haplotype , with similar results) shows that the whole region of around 14 kb presents substantial LD, as described previously, 7 and now confirmed for all the worldwide populations studied, and depending on block definition, it may be contained within a single LD block. A first approach to test whether the amount of LD was similar among populations consisted of taking r 2 values for adjacent SNPs and comparing them among populations, by means of Friedman test, and comparing the average r 2 values of a continental group with the average of all other groups, using Wilcoxon's test. No statistical differences in r 2 values were found among populations. Therefore, populations within continental groups are homogeneous regarding their amounts of LD, as are also all worldwide regional groups. Next, we tested whether the structure of LD was similar by computing the correlation between the same r 2 values between pairs of populations. Comparisons within continental regions showed high correlations between population pairs, all of them being statistically significant (Po0.05). When pairs of populations from different continental regions were compared, the correlations were also significant, with the exception of the two Pygmy populations, which presented low correlation and nonsignificant values with most of the analyzed populations (data not shown). If instead of just taking the diagonal, the whole LD matrix is considered, correlations with Mantel's tests give significant correlation values both between populations pairs within regions (with the exception of Mbuti Pygmies) and for pairs of continental regions (data not shown). Thus, both the amount and pattern of LD in the CTLA4 gene region was similar across human populations.
Considering the high LD in the region, as well as its similarity among populations, we would expect tag-SNPs to be extremely useful for the analysis of the CTLA4 gene and portable across populations. For this purpose, we have defined sets of tag-SNPs for the whole CTLA4 region in our worldwide sample for geographical regions, grouping the population haplotypes in each continent. As shown in Figure 1b , continental regions can be described using only twoto-four tag-SNPs, with geographical regions with higher LD needing less tag-SNPs. It is interesting to note that none of the seven SNPs at the 3 0 -end has been selected as tag-SNP in any continental region, and, in most cases, only those at the 5 0 -end are defined as tag-SNPs. The number of common haplotypes (those with frequencies over 5%) and the fraction of the total haplotypes detectable with the continental tag-SNP sets in each population is shown in Table 3 . The tag efficiency of the tag-SNP sets for each continental region is defined as the frequency of total haplotypes in the population divided by the number of tag-SNPs in the set. For instance, the European tag-SNP set consisted of three SNPs (À1765, À1661 and -658; Figure 1b) scores B88% of the total common haplotypes (which represent B80% of the total European haplotypes). Thus, the detected haplotypes represent B71% of the total European haplotypes, and therefore, the tag efficiency of each of the three SNP in the European tag-SNP set is B24%. As expected, tag efficiency is higher in those regions with stronger LD (ie Oceania and America) and lower in sub-Saharan Africans. Haplotype structure of CTLA4 A Ramı´rez-Soriano et al In a previous study of the CTLA4 region, 6 five tagSNPs were described for the region contained between SNPs -1765 to þ 6249 in UK control individuals. We have tested the original five tag-SNPs defined by Johnson et al 6 (À1722, À1661, À658, À319 and þ 49) to assess their tag efficiency between populations. With this objective, new haplotypes have been estimated considering only the gene region reported in that previous study (ie from positions -1765 to 6249, encompassing nine SNPs). Table 3 shows the fraction of detected haplotypes using the five previously defined tag-SNPs. These tag-SNPs, defined in Europeans, detect B87% of haplotypes among Europeans (population values between 70 and 96%). These values, as expected, are low for Africans and high for Amerindians but, surprisingly, are very high (B94%) for East Asian populations, with population values reaching 99%. These tag-SNPs can be considered portable among populations with the described limitations, that is, from populations needing more tag-SNPs to populations needing less tag-SNPs, but not vice versa.
When the present continental tag-SNPs are applied to the estimated haplotypes from positions -1765 to 6249, the amount of detected haplotypes is similar to the amount provided by the previously defined tag-SNPs, but the efficiency of each tag-SNP (defined as the proportion of the whole variation each one explains) increases dramatically, and these values are similar to those found when the whole region is considered. As in Oceania and Middle East, one of the present tag-SNP lies outside the haplotypes estimated from À1765 to 6249, new tag-SNPs have been recalculated only for this region. In North-Africa, East Asia, Oceania and America, the tag-SNPs have not changed, while in sub-Saharan Africa, Europe and Central/South Asia, one extra SNP is needed and in Middle East three SNPs have been added. This increase in the number of SNPs seen in some continental groups can be explained by the effect of adding some low-frequency haplotypes that shared the first nine SNPs.
Discussion
Polymorphism patterns
The genetic diversity pattern found in the CTLA4 region in SNP and haplotype frequencies, F ST and genetic structure, and LD patterns, agree with the population history of the samples analyzed and the general pattern of diversity that has been shown in other global studies in different gene regions, 19, 21 and therefore can be explained by the 'out-of-Africa' origin of modern humans, with more genetic diversity, less LD and higher heterogeneity among populations in Africa than elsewhere. However, these patterns could have been affected by other processes such as ascertainment bias of the markers or selective pressures.
On the one hand, as the analyzed SNPs were described in European populations, 6, 7 a certain bias in their description could exist. Nevertheless, the present worldwide results do not show this bias as, with minor exceptions especially in Native Americans, all SNPs are universally polymorphic. In fact, SNP ascertainment bias would not be relevant for ascertaining common haplotypes, especially in genetic regions, like the CTLA4, with high LD.
On the other hand, in contrast to population processes that affect the whole genome, gene factors such as differential selection can shape the haplotype structure and LD in specific gene regions and might result in population differences. Since CTLA4 has a key role in the immune system and has been related to autoimmune diseases, the exposure to geographic differential selective pressures, such as the presence of pathogens that could have affected the CTLA4 gene structure, could be envisaged. This has been the case of the selection for resistance to malaria detected in several genes such as G6PD, 37 Duffy 38 and TNFSF5. 39 Although differences among populations in allele frequencies have been found in the CTLA4 gene, none of the SNPs analyzed presented significantly higher F ST values compared to an SNP genomewide distribution of F ST . 35, 36 This fact stresses that the differences among populations are not unexpectedly large and points to a lack of local selective pressures across human populations on the CTLA4 gene, at least in recent times.
The analysis of the CTLA4 region has shown that there is a clear population structure in haplotype frequencies, but there are minor differences in the LD among populations. Thus, genomic processes might have affected all global populations in the same manner, giving similar LD patterns in the CTLA4 region, whereas the differences found, basically in haplotype and SNP Haplotypes estimated using SNPs from À1765 to +6249 (nine SNPs).
c
In brackets, percentage of common haplotypes (frequency 45%). In brackets, percentage of the total common haplotypes (frequency 45%) detectable by using tag-SNPs.
e Only one tag-SNP has been used, since the second tag-SNP lies out of the analyzed region.
Haplotype structure of CTLA4 A Ramı´rez-Soriano et al frequencies, might be explained by demographic processes, such as expansions, founder effects and migrations.
LD patterns
The present study has been performed on a region spanning 14 kb, which has been described as having a low recombination rate (0.3 cM/Mb). 40 This points to high LD over the region, which has already been reported by Ueda et al. 7 Our results not only show this high LD but also that it persists across populations worldwide.
Previous studies in other genes, such as PAH 41 or the PKLR-GBA gene region, 42 have shown a general pattern of moderate geographical structure of LD with higher values out of Africa and low values in sub-Saharan Africa. However, a number of deviations from this overall pattern has been described, ranging from extreme differences between African and non-African populations, such as those found in the CD4 locus, 20 DRD2 43 or DM, 44 among others, to similar LD values in African and non-African populations such as the CFTR gene. 45 The different geographical patterns observed in different loci can be interpreted as the distribution of a stochastic variable, in which CD4 and CFTR would be the opposite extremes. When comparing our results with these previous studies, LD patterns in CTLA4 show a similar pattern to that found in the CFTR region, that is, lack of strong differences among human groups.
Until the present CTLA4 analysis, the only gene related to immunity studied in worldwide samples was CD4. However, their LD patterns do not coincide, as the CD4 locus showed a much higher LD geographical structure than CTLA4. This difference could be related to their function, with possible diversifying selection in CD4 but not in CTLA4, and also it could be due to stochastic variation. More immunity genes should be globally studied to assess whether an LD trend in immunity genes exists.
Tag-SNPs
It would be expected that tag-SNPs would be particularly efficient in the CTLA4 region, given its high LD. A previous study (Gonzalez-Neira et al 46 ) has shown that tag-SNPs are portable among populations even across regional groups, which means that most of the haplotype diversity in different populations can be scored by a unique set of tag-SNPs. However, those results were obtained in a gene-free, low-LD region and may not be extended to other regions with different properties. The present analysis provides some tag-SNP sets for different continental regions that score a large and similar amount of the total haplotype variation. Moreover, these tag-SNP sets appear to be portable between populations within continental regions since no significant differences are found in the amount of haplotype variation detected. In contrast, the portability of these tag-SNP sets between continental regions depends on the number of tag-SNPs that form a continental set. For instance, the sub-Saharan tag-SNP set, formed by four SNPs, would score most of the variation in the rest of the continents, but the scores of the American set applied to other continents would yield poorer results. Therefore, the larger the number of tag-SNPs in a set, the more portable to other geographical regions. Nonetheless, the tag efficiency (defined as the amount of variation detected by each tag-SNP) would be dramatically reduced in some continental areas.
Owing to the high-throughput technologies available, a reduction from 17 to two-to-four SNPs to be typed may seem unnecessary. However, at a whole-genome scale, or with a candidate-gene approach, if such levels of reductions were achieved in each of the hundreds or thousands of genes to be typed, the saving in costs and time would be more than justified, and would certainly allow to increase the number of genes to be typed.
Impact on association studies Up to now, association studies in CTLA4 have led to contradictory results in different populations. Our results show global F ST B10%, that is, that populations worldwide for the CTLA4 gene are not more different from each other than the average calculated in previous studies of neutral markers. [32] [33] [34] However, significant differences in SNP frequencies and haplotype composition exist not only between geographical groups but also, in some cases, within groups. This could explain the contradictions found in the literature, especially considering that association studies work with very large sample sizes, which would make significant small differences not reflected here. These results, then, are a clear indication that the design of new case-control studies should take into account the heterogeneity both at inter-and at intragroup level, and points to the need of a very well matched control population to compare with patients: different ethnic or geographic extraction could easily jeopardize the differences found between both groups.
The knowledge of the haplotype structure and LD patterns in specific regions, such as the CTLA4 gene, in worldwide populations will shed light not only on the population history of the populations analyzed but also on the genomic processes that could be pivotal for biomedical interests. 18 
Materials and methods
Samples
A total of 1262 individuals from 44 human populations were analyzed for the CTLA4 gene region. In all, 38 populations are those from the HGDP-CEPH Human Genome Diversity Cell Line Panel, 47 which contains lymphoblastoid cell lines from 1051 individuals in 51 populations located in all major geographic regions of the world. The rest of populations were chosen to improve the coverage in some geographic areas (Saharawi, Tanzanian, Moroccan, Catalan, Basque and Spanish). All samples were obtained with appropriate informed consent. Sample sizes varies from seven (San) to 71 (Spanish) individuals, most of them having around 25 individuals (Table 1) . Within the HGDP-CEPH panel, some populations represented by a reduced number of individuals were grouped and analyzed together: Continental Italy (North Italian, Tuscan), North China (Daur, Hezhen, Mongola, Oroquen, Tu, Uygur, Xibo) and South China (Dai, Lahu, Miazou, Nai, She, Tujia, Yizu). To elucidate the ancestral state of the SNPs analyzed, DNAs from one chimpanzee (Pan troglodytes), one gorilla (Gorilla gorilla) and one orangutan (Pongo pygmaeus) were used. Table 2 . SNPs mostly encompass the 5 0 and 3 0 regions because these variants are those relevant for disease-association studies and the whole coding region lies within a clear and very strong LD block, 6 ,7 a fact confirmed in the present study.
SNP typing
PCR amplification
The 5 0 -end region containing SNPs from À1765 to þ 49 was amplified using conditions described previously. 17 The 3 0 region containing the rest of the SNPs was amplified in two fragments in a multiplex reaction with the following cycling conditions: 941C for 5 min; 35 cycles of 941C for 30 s, 631C for 30 s and 721C for 45 s; and a final elongation step of 721C for 5 s. PCR products were purified using EXO-SAP (5 units of EXO and 25 units of SAP per reaction), with an incubation of 60 min at 371C followed by 15 min at 721C to inactivate the enzyme.
SNaPshot reaction
All SNPs were typed using the SNaPshott Multiplex technique (Applied Biosystems), a single-base primer extension method that uses labelled ddNTPs to interrogate SNPs. The single-base primer extension was performed following supplier's recommendations using different primer lengths. Two different SNaPshot reactions were performed, one for the 5 0 -end and first exon SNPs and the other for the 3 0 -end SNPs. Unincorporatedlabelled ddNTPs were removed by adding one unit of CIP to the primer extension products for 60 min at 371C followed by 15 min at 721C to inactivate the enzyme. Products were analyzed in an ABI PRISM3100 and ABI PRISM GeneScan Analysis Software v3.7 (Applied Biosystems). LIZ-120 (Applied Biosystems) was used as size marker.
In order to check the accuracy of the SNaPshot technique, SNP 6230 was also genotyped for the worldwide diversity panel with TaqMan's Assays-by-Design SM service (Applied Biosystems), which consisted of a mix of unlabelled PCR primers and TaqMan s MGB probes (FAMt and VIC s dye-labelled). We performed the assay using TaqMan Universal PCR Master Mix following supplier's recommendations. Results were analyzed using SDS software package version 2.1 (Applied Biosystems). There were minor discrepancies between TaqMan and SNaPshot genotypes (three samples of the panel were scored as heterozygotes by the SNaPshot technique and as homozygotes by TaqMan), which implies that the SNaPshot genotype assignment is 99.7% concordant with the TaqMan assays.
Ancestral-type inference
All SNPs were typed in three primate individuals, one chimpanzee (P. troglodytes), one gorilla (G. gorilla) and one orangutan (P. pygmaeus) as described above. Since some of the SNPs were difficult to type in the primates using the SNaPshot technology, we sequenced the fragment containing the seven SNPs located at the 5 0 -end of the gene and the SNP 10 717 in the three primates. Sequence was carried out using the following cycling conditions: 3 min at 941C and 25 cycles of 961C 10 s, 501C 5 s and 601C 4 min; and precipitated using BigDyes 3.0 protocol (Applied Biosystems). Chimpanzee results have also been checked using the chimpanzee genome in Ensembl (http://www.ensembl.org/) and the ancestral positions have been determined using the approach in Iyengar et al. 48 
Data analysis
Haplotype frequencies were estimated using a Bayesian algorithm as implemented in the PHASE package version 2.0. 49 Populations with sample sizes of less than 20 chromosomes (namely, the San) were dropped from the haplotype analyses given the high uncertainty associated with the haplotype estimation.
F ST gives a measure of the proportion of the genetic variance explained by differences among populations. Incorporating the molecular distance between alleles to F ST , F ST is obtained. Hardy-Weinberg equilibrium, F ST and F ST values, and AMOVA were calculated using Arlequin software. 50 LD measures D 0 and r 2 were calculated using Haploview.
Friedman and Wilcoxon nonparametric tests were performed using Statistica. Mantel tests to compare r 2 matrices were computed using Passage version 1.0. Comparisons were made between populations within each continental group. Subsequently, r 2 values were recalculated for populations pooled into geographical groups and Mantel tests were applied.
We computed the FNF statistic, 45 which can be interpreted as the fraction of haplotypes not found in a population, where the number of haplotypes expected under linkage equilibrium, given the sample size and the allele frequencies, is compared with the number of observed haplotypes in each population. It can be calculated as FNF ¼ 1ÀKh/Kmax, where Kh is the number of haplotypes found in the sample and Kmax is the maximum possible number of different haplotypes expected under total linkage equilibrium given the size and allele frequencies of the population. FNF values are independent of the number of loci and are expected to increase with LD.
New tag-SNPs were described both using htSNP2 6 (http://wwwgene.cimr.cam.ac.uk/clayton/software/stata/) and BEST. 51 These two programs identify the minimum set of SNPs accounting for a given minimum fraction of the genomic variation. One method to define htSNPs, implemented in htSNP2, seeks to find the minimum set of SNPs so that the proportion of the total variance explained (as measured by the multiple regression R 2 statistic) is above a certain threshold (0.8 in our case). The second algorithm used, implemented in BEST, takes as input a set S of haplotypes. The algorithm returns a minimal set of SNPs from which all of the other SNPs in the haplotype set can be derived. The tag-SNPs obtained using htSNP2 are concordant with the ones obtained with BEST (or, in the cases where BEST provides more than one set, coincident with one of them). Haplotype tag-SNP portability was tested using htSNP2.
